Perspectives on allergen-specific immunotherapy in childhood: An EAACI position statement

ABSTRACT: This article is the result of consensus reached by a
working group of clinical experts in paediatric allergology as well as
representatives from an ethical committee and the European Medicine Agency (EMA).
The manuscript covers clinical, scientific, regulatory and ethical perspectives
on allergen-specific immunotherapy in childhood. Unmet needs are identified. To
fill the gaps and to bridge the different points of view, recommendations are
made to researchers, to scientific and patient organizations and to regulators
and ethical committees. Working together for the benefit of the community is
essential. The European Academy of Allergy and Clinical Immunology (EAACI) serves
as the platform of such cooperation.